Improve your mesothelioma service by forming a network: the 🏴 experience by Matthew Tate
🟢 ⬆️ data completeness
🟢 ⬇️ non-biopsy cases
🟢 ⬆️ OS in non-epithelioid
🔺 OS benefit not solely due to arrival of immunotherapy
@btog.bsky.social
@mesouk.bsky.social
🟢 ⬆️ data completeness
🟢 ⬇️ non-biopsy cases
🟢 ⬆️ OS in non-epithelioid
🔺 OS benefit not solely due to arrival of immunotherapy
@btog.bsky.social
@mesouk.bsky.social
1 / 4
Comments